India has long carried the reputation of being the diabetes capital of the world. But that title, which once seemed like a demographic statistic, has now turned into a looming healthcare disaster. Today, the country is not just managing an explosion of diabetes cases but also quietly watching a parallel crisis unfold. An alarming rise in vision loss caused by diabetic retinopathy. While numbers grow on paper, thousands of Indians are silently slipping into darkness. And the tragedy is not just in the disease but in the delay.

Diabetic retinopathy, an eye condition caused by prolonged high blood sugar damaging the retina, is steadily becoming one of the most common causes of preventable blindness in India. This is not a fringe problem restricted to a small percentage. With millions already diagnosed with diabetes and millions more teetering on the edge, the risk is no longer hypothetical. Retinal damage doesn’t give warnings. It doesn’t cause pain. And it doesn’t wait for the patient to be prepared. By the time most people realize something is wrong, the damage is already severe and often irreversible.

In 2019 alone, the country recorded over a million diabetes-related deaths. But behind that grim number lies a broader, hidden burden of the countless cases of lost productivity, disrupted lives, and emotional turmoil due to blindness that could have been avoided. It is estimated that nearly one in every six diabetics in India already has signs of retinal damage, and a worrying number are on the brink of complete vision loss. What makes this more unsettling is the widespread ignorance, both among patients and in the healthcare system, about how to handle this silent threat.

The primary cause isn’t just the disease it’s the delay. Delay in screening. Delay in awareness. Delay in intervention.

While urban hospitals in major cities have some form of retina screening in place, the outreach in rural India where a massive population of diabetics resides is staggeringly poor. The infrastructure gaps are wide. Many primary health centres lack even the most basic tools to check for early retinal changes. And even when these tools are available, the workforce is either untrained or stretched too thin to prioritise retinal health. A patient may get diabetes medication and advice to manage sugar, but rarely are they informed that diabetes could steal their sight unless they proactively get their eyes examined.

This delay in information is deadly. Many patients do not even know that diabetic retinopathy exists until their vision starts blurring or they start losing peripheral sight. And by then, both financial and personal loss is immense. Regular screening could catch the earliest signs of damage, allowing for timely intervention through medication, laser therapy, or even simple lifestyle modifications. But instead, we allow time to slip by and with it, people's vision.

A recent discussion among leading ophthalmologists and diabetologists highlighted what experts have been shouting for years, retinal screening must not be optional for diabetics. It should be a right. Every diabetic, regardless of geography or economic status, should have access to annual retinal check-ups as a part of their routine care. This means integrating diabetic retinopathy screening into national programmes like Ayushman Bharat and ensuring it’s available across the country, not just in select states.

But implementing this vision will require more than policy statements. It will take political will, financial investment, and a change in how we view chronic illness care. The healthcare system must move from reactive to proactive. From cure to prevention. And from centralised care to decentralised access.

One of the most promising solutions lies in technology. Artificial Intelligence-based screening tools have shown remarkable accuracy in identifying diabetic retinopathy at an early stage. With proper regulation and training, these AI systems can be deployed in primary health centres, allowing trained technicians to screen patients with the help of non-invasive fundus cameras. States like Rajasthan and Kerala have already begun experimenting with such technology. The early results are encouraging. With minimal training, healthcare workers can now identify at-risk individuals and refer them for specialised care. In many cases, this is the difference between sight and blindness.

Yet, despite such tools being available, widespread adoption remains slow. Budget constraints, bureaucratic red tape, and a general lack of urgency have hindered progress. There’s also an absence of public demand. Most people do not ask their doctors about their eyes. And most doctors, unless they specialise in ophthalmology, often forget to refer diabetics for retinal screening unless symptoms are already visible.

This gap in awareness is where the media, healthcare communicators, and NGOs have a role to play. We need large-scale, national campaigns that educate people about the risks of diabetic retinopathy. Campaigns that remind every diabetic that saving their vision is within their control but only if they act early. Posters in hospitals, alerts via mobile apps, reminders through SMS, and even messages printed on prescription slips could go a long way in changing patient behaviour.

But awareness alone won't be enough unless it’s backed by access. A person who is told to get their eyes checked must find a centre within reach to do so. Mobile screening vans, district-level retina camps, and community eye-health initiatives must be revived and scaled up. Medical colleges and hospitals can tie up with regional centres to make screening seamless and cost-effective.

India already has the diagnostic tools, expert knowledge, and technological edge to curb the rise of diabetic blindness. What it needs now is urgency. The country cannot afford to let millions go blind from a condition that is entirely preventable. The cost of ignoring diabetic retinopathy is more than financial. It’s the emotional trauma of losing independence, the burden on families, and the social cost of caring for individuals who could have continued living full, productive lives with timely support.

The coming decade offers India a unique opportunity. If diabetic retinopathy screening is recognised as a national priority by 2030, and if the government, private players, and citizens come together to make early detection the norm, not the exception, then we might see a dramatic shift. We might go from being the diabetic capital of the world to the first country to effectively control vision loss caused by diabetes.

But for that to happen, the system must move. Doctors must recommend screening. Patients must seek it. Policymakers must fund it. And the healthcare community must push relentlessly for it.

Time is slipping. And with every passing year, more lives fall into darkness. India must ask itself a hard question. How long will we continue to look the other way while millions lose theirs?